Skip to main content
Log in

IPAF – „Interstitial pneumonia with autoimmune features“

Unzureichende Evidenz und das Berlin-Brandenburger IPAF-Register

IPAF – interstitial pneumonia with autoimmune features

Insufficient evidence and the Berlin-Brandenburg IPAF register

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Autoimmunerkrankungen mit Lungenbeteiligung sind gut charakterisiert. In der Praxis gibt es diffuse Lungenparenchymerkrankungen unklarer Ursache, aber mit möglichen Hinweisen auf eine Autoimmunerkrankung, ohne dass eine definitive rheumatologische Diagnose gestellt werden kann. In 2015 veröffentlichte eine Arbeitsgruppe der European Respiratory Society (ERS) und der American Thoracic Society (ATS) einen Klassifikationskatalog zur IPAF („interstitial pneumonia with autoimmune features“), nachdem zuvor unterschiedliche Klassifikationssysteme existierten. Diese Arbeit bietet einen Überblick über aktuelle Evidenz zum Thema IPAF sowie einen Ausblick auf das im Aufbau befindliche Berlin-Brandenburger IPAF-Register. Die Evidenz wurde mittels narrativer PubMed-Recherche gesucht. Zielsetzung und Projektdesign des Registers werden dargestellt. Die Evidenz zu IPAF ist limitiert. Nach Veröffentlichung der ERS/ATS-Kriterien wurden nur wenige, retrospektive Evaluationsstudien publiziert. Der Parameterkatalog des Berlin-Brandenburger IPAF-Registers bildet IPAF-Krankheitsverläufe umfassend ab. Eine Online-Datenplattform für prospektive, multizentrische Langzeitbeobachtungen wurde programmiert. Nach einer Pilotphase ist eine Ausweitung des Datenregisters auf die Region Berlin-Brandenburg geplant. Eine exakte Abgrenzung von idiopathischen interstitiellen Pneumonien (IIP), IPAF und Kollagenosen („connective tissue diseases“, CTD) mit pulmonalen Manifestationen ist weiterhin schwierig. Eine noch intensivere multidisziplinäre Zusammenarbeit von Rheumatologen, Pneumologen, Radiologen, Pathologen und Labormedizinern ist daher anzustreben. Zur Verbesserung der Evidenzbasis können prospektive Patientenregister wie das Berlin-Brandenburger IPAF-Register eine wertvolle Hilfe darstellen.

Abstract

Interstitial pneumonia in patients with connective tissue diseases (CTD) is a well-characterized entity. Several patients with interstitial pneumonia, however, show some features of CTD without having a definitive diagnosis of CTD. In 2015, a European Respiratory Society (ERS) and American Thoracic Society (ATS) task force issued a classification catalogue for interstitial pneumonia with autoimmune features (IPAF). Prior to this, divergent classification systems existed. This article provides an overview of current IPAF evidence as well as an outlook on the Berlin-Brandenburg IPAF registry. The evidence was searched for by means of a narrative PubMed search. Objectives and project design of the registry under construction are presented. The evidence for IPAF is limited. After publication of the ERS/ATS criteria, only a few retrospective observational studies were published. The parameter catalogue of the Berlin-Brandenburg IPAF register comprehensively maps the IPAF disease continuum. An online data platform for prospective, multicenter long-term observations has been programmed. After a pilot phase, an extension of the data register to the region of Berlin-Brandenburg is envisaged. A precise differentiation of idiopathic interstitial pneumonia, IPAF and connective tissue diseases with pulmonary manifestations remains difficult. An even more intensive multidisciplinary cooperation of rheumatologists, pulmonologists, radiologists, pathologists and laboratory physicians is therefore desirable. To improve the evidence basis, prospective patient registries such as the Berlin-Brandenburg IPAF registry can be a valuable aid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V, CTD-ILD EATFoUFo (2015) An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976–987

    Article  CAS  PubMed  Google Scholar 

  2. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr. (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176(7):691–697

    Article  PubMed  PubMed Central  Google Scholar 

  3. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU (2012) Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 39(3):661–668

    Article  CAS  PubMed  Google Scholar 

  4. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 138(2):251–256

    Article  PubMed  PubMed Central  Google Scholar 

  5. Vij R, Noth I, Strek ME (2011) Autoimmune-featured interstitial lung disease: a distinct entity. Chest 140(5):1292–1299

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kim HC, Ji W, Kim MY, Colby TV, Jang SJ, Lee CK, Han SB, Kim DS (2015) Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis. Chest 147(1):165–172

    Article  PubMed  Google Scholar 

  7. Kondoh Y, Johkoh T, Fukuoka J, Arakawa H, Tanaka T, Watanabe N, Sakamoto K, Kataoka K, Kimura T, Taniguchi H (2015) Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias. Respir Med 109(3):389–396

    Article  PubMed  Google Scholar 

  8. Omote N, Taniguchi H, Kondoh Y, Watanabe N, Sakamoto K, Kimura T, Kataoka K, Johkoh T, Fujimoto K, Fukuoka J, Otani K, Nishiyama O, Hasegawa Y (2015) Lung-dominant connective tissue disease: clinical, radiologic, and histologic features. Chest 148(6):1438–1446

    Article  PubMed  Google Scholar 

  9. Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE Jr., Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS (2015) Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med 109(10):1326–1331

    Article  PubMed  Google Scholar 

  10. Pan L, Liu Y, Sun R, Fan M, Shi G (2013) Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study. Clin Dev Immunol. https://doi.org/10.1155/2013/121578

    Google Scholar 

  11. Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, Strek M, Thivolet-Bejui F, Traclet J, Cottin V (2017) Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 123:56–62

    Article  PubMed  Google Scholar 

  12. Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A (2016) Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med 119:150–154

    Article  PubMed  Google Scholar 

  13. Chung JH, Montner SM, Adegunsoye A, Lee C, Oldham JM, Husain AN, MacMahon H, Noth I, Vij R, Strek ME (2017) CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features. AJR Am J Roentgenol 208(6):1229–1236

    Article  PubMed  Google Scholar 

  14. Ito Y, Arita M, Kumagai S, Takei R, Noyama M, Tokioka F, Nishimura K, Koyama T, Notohara K, Ishida T (2017) Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 17(1):111

    Article  PubMed  PubMed Central  Google Scholar 

  15. Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek ME (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47(6):1767–1775

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Adegunsoye A, Oldham JM, Valenzi E, Lee C, Witt LJ, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek ME, Husain AN (2017) Interstitial pneumonia with autoimmune features: value of histopathology. Arch Pathol Lab Med 141(7):960–969

    Article  PubMed  Google Scholar 

  17. Yamakawa H, Hagiwara E, Kitamura H, Yamanaka Y, Ikeda S, Sekine A, Baba T, Iso S, Okudela K, Iwasawa T, Takemura T, Kuwano K, Ogura T (2016) Clinical features of idiopathic interstitial pneumonia with systemic sclerosis-related autoantibody in comparison with interstitial pneumonia with systemic sclerosis. PLoS ONE 11(8):e161908

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mejia M, Herrera-Bringas D, Perez-Roman DI, Rivero H, Mateos-Toledo H, Castorena-Garcia P, Figueroa JE, Rojas-Serrano J (2017) Interstitial lung disease and myositis-specific and associated autoantibodies: clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). Respir Med 123:79–86

    Article  PubMed  Google Scholar 

  19. Collins BF, Spiekerman CF, Shaw MA, Ho LA, Hayes J, Spada CA, Stamato CM, Raghu G (2017) Idiopathic interstitial pneumonia associated with autoantibodies: a large case series followed over 1 year. Chest 152(1):103–112

    Article  PubMed  Google Scholar 

  20. Kono M, Nakamura Y, Yoshimura K, Enomoto Y, Oyama Y, Hozumi H, Enomoto N, Fujisawa T, Inui N, Hamada E, Colby TV, Maekawa M, Suda T (2016) Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease. Respir Med 117:40–47

    Article  PubMed  Google Scholar 

  21. Hu Y, Wang LS, Wei YR, Du SS, Du YK, He X, Li N, Zhou Y, Li QH, Su YL, Zhang F, Shen L, Weng D, Brown KK, Li HP (2016) Clinical characteristics of connective tissue disease-associated interstitial lung disease in 1,044 Chinese patients. Chest 149(1):201–208

    Article  PubMed  Google Scholar 

  22. Fischer A, Collard HR, Cottin V (2016) Disease EATFoUFoCTD-aIL. Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 47(4):1295–1296

    Article  PubMed  Google Scholar 

  23. Moua T, Zamora Martinez AC, Baqir M, Vassallo R, Limper AH, Ryu JH (2014) Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res 15:154

    Article  PubMed  PubMed Central  Google Scholar 

  24. Suzuki A, Kondoh Y, Fischer A (2017) Recent advances in connective tissue disease related interstitial lung disease. Expert Rev Respir Med 11(7):591–603

    Article  CAS  PubMed  Google Scholar 

  25. Cottin V (2016) Idiopathic interstitial pneumonias with connective tissue diseases features: a review. Respirology 21(2):245–258

    Article  PubMed  Google Scholar 

  26. Catrina AI, Svensson CI, Malmstrom V, Schett G, Klareskog L (2017) Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol 13(2):79–86

    Article  CAS  PubMed  Google Scholar 

  27. Roubille C, Haraoui B (2014) Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 43(5):613–626

    Article  CAS  PubMed  Google Scholar 

  28. Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C, Della Casa G, Cerri S, Torricelli P, Luppi F (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15(1):61–70

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Blum.

Ethics declarations

Interessenkonflikt

T. Blum, A. Gerber, T. Bauer, C. Fléchet, S. Griff, C. Großwendt, B. Rehbock, H. Rüssmann, N. Schönfeld und A. Krause geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

P. Kardos, Frankfurt

W. Randerath, Solingen

T. Blum und A. Gerber teilen sich die Erstautorenschaft. T. Bauer und A. Krause teilen sich die Letztautorenschaft.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blum, T., Gerber, A., Fléchet, C. et al. IPAF – „Interstitial pneumonia with autoimmune features“. Pneumologe 15, 103–112 (2018). https://doi.org/10.1007/s10405-017-0164-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-017-0164-4

Schlüsselwörter

Keywords

Navigation